inyecciones semaglutide Nuevo estudio: revelan los múltiples efectos secundarios de Ozempic, algunos impensados Lanzan en la Argentina un

doi:10.1016/j.rvsc.2023.05.007

The peptide received FDA approval in June 2019 under the brand name Vyleesi for treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women, establishing it as a first-in-class medication with a novel mechanism distinct from all previous sexual dysfunction treatments

Acknowledgments We thank Figdraw ( for help with the graphics

For US patients today, the actionable strategy is clear: do not defer treatment waiting for a generic that is years away

The Ozempic baby phenomenon As ovulation returns and cycles become more regular, some women on GLP-1 medications have experienced unexpected pregnancies sometimes called Ozempic babies. This can happen because weight loss and improved insulin sensitivity may restore ovulation in previously anovulatory patients, especially those with PMOS (formerly PCOS)